ANI Pharmaceuticals Inc’s filing revealed that its SR. VP, GENERAL COUNSEL & SEC. Cook Meredith unloaded Company’s shares for reported $24548.0 on Jun 13 ’25. In the deal valued at $61.37 per share,400 shares were sold. As a result of this transaction, Cook Meredith now holds 79,345 shares worth roughly $5.03 million.
Then, Gutwerg Ori sold 881 shares, generating $52,922 in total proceeds. Upon selling the shares at $60.07, the SVP, GENERICS now owns 89,897 shares.
Before that, Mutz Christopher sold 4,000 shares. ANI Pharmaceuticals Inc shares valued at $241,800 were divested by the HEAD OF RARE DISEASE at a price of $60.45 per share. As a result of the transaction, Mutz Christopher now holds 107,317 shares, worth roughly $6.8 million.
Jefferies initiated its ANI Pharmaceuticals Inc [ANIP] rating to a Buy in a research note published on March 14, 2025; the price target was $80. A number of analysts have revised their coverage, including JP Morgan’s analysts, who began to cover the stock in mid March with a ‘”an Overweight”‘ rating. Leerink Partners began covering ANIP with “an Outperform” recommendation on December 11, 2024. Piper Sandler started covering the stock on October 11, 2024. It rated ANIP as “an Overweight”.
Price Performance Review of ANIP
On Tuesday, ANI Pharmaceuticals Inc [NASDAQ:ANIP] saw its stock fall -1.46% to $63.35. Over the last five days, the stock has gained 0.76%. ANI Pharmaceuticals Inc shares have risen nearly 14.60% since the year began. Nevertheless, the stocks have risen 0.17% over the past one year. While a 52-week high of $77.00 was reached on 05/09/25, a 52-week low of $52.50 was recorded on 01/13/25.
Levels Of Support And Resistance For ANIP Stock
The 24-hour chart illustrates a support level at 62.74, which if violated will result in even more drops to 62.12. On the upside, there is a resistance level at 64.58. A further resistance level may holdings at 65.80.
The most recent change occurred on March 15, 2024 when CapitalOne began covering the stock and recommended ‘”an Overweight”‘ rating along with a $80 price target.
